Clinical trial data and analytics platform with biometrics services
eClinical Solutions pairs its elluminate clinical data platform with biometrics services for life sciences sponsors. The stack spans nearly every major BI and ETL tool (Qlik, Spotfire, Tableau, Informatica, DataStage, SAS) across AWS, Azure and Snowflake, a sign the platform must ingest from heterogeneous client environments. Data-heavy, senior-skewed hiring in the US and India lines up with work on a next-generation platform and AI-assisted workflows.
eClinical Solutions provides elluminate, a data and analytics platform for clinical trials, alongside biometrics services such as clinical data management, EDC services, statistical programming and biostatistics. Its clients are biopharma and life sciences organizations ranging from emerging companies to large enterprises. The company was founded in 2012, is privately held and headquartered in Mansfield, MA. It employs 201–500 people and hires in the United States and India.
Core technologies include .NET, C#, Python, Java, Angular, Blazor and TypeScript, with data tooling such as Snowflake, SQL Server, Apache Spark, Informatica, SAS and Qlik on AWS and Azure.
Job posts point to a next-generation clinical data and analytics platform, AI-assisted workflow integration, clinical software integrations, SDTM dataset specifications and SAE reconciliation across trial databases.
eClinical Solutions hires in the United States and India, with demand concentrated in data and engineering roles at senior and principal levels. Headquarters is in Mansfield, MA.
Other companies in the same industry, closest in size
eClinical Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.